Rising Sports Injuries Fuel Growth In Osteoarthritis Therapeutics Market: The Driving Engine Behind Osteoarthritis Therapeutics Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Osteoarthritis Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the osteoarthritis therapeutics market has seen substantial growth. The market size was $8.17 billion in 2024 and is projected to rise to $8.87 billion in 2025, reflecting an annual compound growth rate (CAGR) of 8.6%. Factors contributing to this progress during the historic period include an aging population, evolution in drug delivery systems, growing awareness and diagnosis, creation of new therapies and an increase in obesity rates.

How Will the Osteoarthritis Therapeutics Market Size Evolve and Grow by 2029?
The size of the market for osteoarthritis therapeutics is expected to experience a significant expansion in the coming years. The market is predicted to reach a value of $12.22 billion by 2029, with a compound annual growth rate (CAGR) of 8.3%. The anticipated growth can be attributed to factors such as an increase in obesity, advancements in treatment techniques, increased awareness and diagnosis, the emergence of disease-modifying osteoarthritis drugs (DMOADs), and the availability of government and private funding for research. Key trends for the future include a growing emphasis on personalized medicine, the development of regenerative therapies, the expansion of options for managing pain, supportive government regulations, and increasing demand in developing markets.

View the full report here:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-therapeutics-global-market-report

What Drivers Are Propelling the Growth of Osteoarthritis Therapeutics Market Forward?
The surge in sports-related injuries is anticipated to drive the expansion of the osteoarthritis therapeutics market. Sports injuries denote any harm or impairment suffered during athletic or sporting activities. The severity of these injuries can vary from minor to major and they can influence different parts of the body. The escalation in sports injuries can be attributed to the increased involvement in sporting activities and the heightened intensity and rivalry within these games. Therapies for osteoarthritis play a key role in managing discomfort and inflammation, as well as enhance joint function in athletes who are grappling with joint deterioration. For instance, the National Safety Council, a nonprofit organization in the US advocating for health and safety, reported that the number of injuries from sports and recreational activities experienced a growth of 12% in 2022. Hence, the burgeoning number of sports injuries is fuelling the expansion of the osteoarthritis therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19634&type=smp

Which Emerging Trends Are Transforming the Osteoarthritis Therapeutics Market in 2025?
Leading entities in the osteoarthritis therapeutics market are fixated on developing ground-breaking solutions, including new innovations for tissue regeneration within the context of osteoarthritis. The concept of tissue regeneration in osteoarthritis involves the repair or replacement of damaged cartilage and joint tissues to resume normal functionality and reduce pain. For example, in May 2023, the Advanced Research Projects Agency for Health (ARPA-H), a governmental organization in the US, unveiled the Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) project. The NITRO initiative, launched by the ARPA-H, is concentrated on creating top-notch injectable therapies that trigger cartilage repair by employing biological pathways akin to those utilized during embryonic development. Exclusive features comprise a cooperative multimodal strategy within research groups and sophisticated testing methods such as the "joint-on-a-chip" systems that mirror joint conditions, with the intent of producing regenerative solutions that tackle the key causes of osteoarthritis.

What Are the Key Segments in the Osteoarthritis Therapeutics Market?
The osteoarthritis therapeuticsmarket covered in this report is segmented -

1) Drug Type: Viscosupplementation Agents, Nonsteroidal Anti-inflammatory Drugs, Analgesics, Corticosteroids, Other Drug Types
2) By Anatomy: Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, Other Anatomies
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Sales Channel: Prescription Drugs, Over-the-Counter Drugs
5) By End-use: Hospital Pharmacies, Retail Pharmacies, Other End-uses

Subsegments:
1) Viscosupplementation Agents: Hyaluronic Acid Injections, Single-Injection Products, Multi-Injection Products
2) Nonsteroidal Anti-inflammatory Drugs: Oral NSAIDs, Topical NSAIDs, COX-2 Inhibitors
3) Analgesics: Opioid Analgesics, Non-Opioid Analgesics, Topical Analgesics
4) Corticosteroids: Injectable Corticosteroids, Oral Corticosteroids, Intra-Articular Corticosteroids
5) Other Drug Types: Disease-Modifying Osteoarthritis Drugs (DMOADs), Platelet-Rich Plasma Therapy, Stem Cell Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19634&type=smp

Who Are the Key Players Shaping the Osteoarthritis Therapeutics Market's Competitive Landscape?
Major companies operating in the osteoarthritis therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Daiichi Sankyo Company Limited, Zimmer Biomet Holdings Inc., Horizon Therapeutics plc, Taisho Pharmaceutical Co. Ltd., Ferring Pharmaceuticals, Galapagos NV, Bioventus LLC, Flexion Therapeutics Inc., Anika Therapeutics Inc., Seikagaku Corporation, Samumed LLC, Orthogen AG, Kolon Life Science Inc.

What Geographic Markets Are Powering Growth in the Osteoarthritis Therapeutics Market?
North America was the largest region in the osteoarthritis therapeutics market in 2022. The regions covered in the osteoarthritis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19634

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.